EnBridge PharmTech (Wuxi) Co., Ltd.

EnBridge PharmTech (Wuxi) Co., Ltd. was founded in 2013 and located in Wuxi, Jiangsu. It is a comprehensive enterprise integrating R&D, production, integrated global supply solutions and import & export services. Our industrial foundation comes from the professional R&D laboratory established in Wuhan in 2016. The Jingmen production base was prepared for construction in 2020. In 2022, EnBridge became a shareholder through strategic investment, officially forming an integrated system featuring R&D in Wuhan, Production in Jingmen, and Global Supply & Distribution in Wuxi. The company independently produces pharmaceutical intermediates, and provides one-stop supply and integrated services for fine chemicals, APIs, food additives, cosmetic raw materials, healthcare raw materials and textile auxiliaries. Relying on the strong R&D capability of Wuhan laboratory and the large-scale production capacity of Jingmen base, we provide professional one-stop CRO/CDMO services focused on pharmaceutical intermediates for global customers, including custom synthesis, process optimization, pilot scale-up and commercial customized production. With strict quality control, stable supply chain and professional international services, our products are exported to many countries and regions. We have established long-term stable strategic partnerships with enterprises in pharmaceutical, fine chemical, food, cosmetic, healthcare and textile industries. Adhering to the philosophy of “Quality First, Win-Win with Integrity”, we are committed to becoming a trusted comprehensive service provider in the global pharmaceutical and chemical industry.